SHANGHAI HENLIUS BIOTECH INC revenue breakdown overview

SHANGHAI HENLIUS BIOTECH INC revenue for the last year amounted to 6.09 B HKD, the most of which — 6.21 B HKD — came from its highest performing source at the moment, Biopharmaceutical, the year earlier bringing 5.96 B HKD. The greatest contribution to the revenue figure was made by China — last year it brought SHANGHAI HENLIUS BIOTECH INC 5.47 B HKD, and the year before that — 5.32 B HKD.